Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 27270401
Park YH, Wood G, Kastner DL, Chae JJ (2016) Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol 17, 914-21 27270401
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S208-p - pyrin (human)
Modsite: VRLRRNAssAGRLQG SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S208‑p, pyrin (mouse): S205‑p, pyrin (rat): Q204‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  macrophage-bone marrow, mononuclear-blood
Cellular systems studied:  cell lines
Species studied:  human, mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PKN2 (human)
KINASE PKN1 (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKN1 (human) phospho-antibody, activation of upstream enzyme, co-immunoprecipitation
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
14-3-3 epsilon (human) Induces co-immunoprecipitation
Comments:  turns off pyrin inflammasome activation

S209-p - pyrin (human)
Modsite: RLRRNAssAGRLQGL SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S209‑p, pyrin (mouse): S206‑p, pyrin (rat): L205‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  macrophage-bone marrow, mononuclear-blood
Cellular systems studied:  cell lines
Species studied:  human, mouse

S242-p - pyrin (human)
Modsite: SGKMRPRsLEVTIST SwissProt Entrez-Gene
Orthologous residues
pyrin (human): S242‑p, pyrin (mouse): S241‑p, pyrin (rat): V238‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Relevant cell lines - cell types - tissues:  macrophage-bone marrow, mononuclear-blood
Cellular systems studied:  cell lines
Species studied:  human, mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PKN1 (human)
KINASE PKN2 (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKN1 (human) phospho-antibody, activation of upstream enzyme, co-immunoprecipitation
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
14-3-3 epsilon (human) Induces co-immunoprecipitation
Comments:  turns off pyrin inflammasome activation